Valens uses mono-cropping to stand out from their competitors
Valens GroWorks Corp. (CSE: VGW) is a Canadian publicly traded biotechnology company executing on its “plants to premium products” objectives through three wholly-owned subsidiaries, located at the Company’s 25,000 square foot facility and greenhouse development in the heart of British Columbia’s Okanagan Valley.
Hannah Bernard: Hi, I’m Hannah Bernard. You’re watching Market One Minute and today I am joined by Tyler Robson of Valens. So, a pretty hot topic in your industry right now. Canada is the first G7 country to legalize recreational cannabis. What does this mean for Canada? And what does it mean for Valens?
Tyler Robson: It gives Valens and all of Canada the ability to cement ourselves in the future of the cannabis industry internationally. So, everyone is super excited getting geared up for the international play which is coming very, very soon.
Hannah Bernard: And everyone’s kind of throwing around these words of premium and quality. What does that mean to Valens?
Tyler Robson: Transparency. At the end of the day, anybody can say it’s a premium product or a quality product. We’re all about transparency. So, from seed to sale, we are very transparent in everything we do as far as extractions and cultivation in everything to the point of sale.
Hannah Bernard: And it’s my understanding that you have a greenhouse joint venture in the works called Valens Farms. So, talk a little bit about the project. How does it differ from similar projects in the industry?
Tyler Robson: Yeah so, it’s actually completely different than most other facilities in Canada for sure because it is a state-of-the-art purpose built facility, that we’re actually mono-cropping in. So, what mono-cropping means is actually each segment of the greenhouse is actually specifically for cultivation. So, each strain or phenotype has unique needs. We actually break those up in a different sections. So, unlike some of our competitors, where they have 40 strains in one room. We only do one strain per one room to really maximize every benefit of the medicinal cannabis plant.
Hannah Bernard: Very interesting. And with regards to partnerships that you have in the industry, talk about the relationships with SpeakEasy and Canopy.
Tyler Robson: Yeah, so I can’t say enough good things about the partnerships we have signed up for, especially Canopy. They’re the largest cannabis company in the world and they’ve been tremendous with opening their distribution channels all over the world, including the European Union, which is the largest cannabis market.
Hannah Bernard: And, you seem very passionate about this industry. You seem to know a lot about it. Where does that passion come from for you? And how did you get started in this industry?
Tyler Robson: I got recruited out of university; I graduated from University of Saskatchewan, and it’s more about changing the negative stigma. This plant can do a lot of good for a lot of people and it’s really breaking through the barriers of the negative connotation with the cannabis plant to really show people what good it can do.
Hannah Bernard: It’s a very exciting time in the industry. We have an investor audience here. Tell them why Valens is a good investment opportunity.
Tyler Robson: Valens is the best investment opportunity around because we’re state of the art, we’re purpose built, we’re building a brand new state-of-the-art facility custom built for cannabis, that is very different from the sector. A lot of people are retrofitting and inheriting problems; we’re purpose building everything we do.
Hannah Bernard: Well it sounds like an exciting time for the company. Thanks for being with us Tyler.
Tyler Robson: Thank you.